Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 1999

View Archived Issues

Key proteomics patents issued to Oxford GlycoSciences

Licensing opportunity from Peptech: anti-TNF antibodies with a range of therapeutic applications

Banyu reviews new product pipeline

New cysteine protease inhibitors from SB for osteoporosis, arthritis, etc.

Hybridon develops antisense oligonucleotides to thymidylate synthase

Sydnonimine derivatives for cardiovascular disorders presented by Chugai

Taiho synthesizes novel compounds for bone metabolism disorders

Novel condensed pyridazines claimed by Takeda for allergic conditions

Peripherally selective kappa-opioid agonists in early development at Warner-Lambert

Excellent clinical results reported for ID Biomedical's rapid MRSA test; February filing announced

Seven-day treatment with AIT-082 leads to memory improvement in elderly volunteers

Scios AD research partnership with Lilly extended

Generic smoking cessation aid receives tentative FDA approval

Medarex receives milestone payment from Centocor related to HuMAb-Mouse technology

GelTex reports success with first- and second-generation cholesterol-lowering compounds

Nankai University team describes new compound with antileukemia activity

New antibiotic isolated and characterized at the Institute of Microbial Chemistry in Tokyo

Antibiotic produced by unidentified fungus shows activity against resistant bacteria

FDA advisory committee reaches positive conclusions regarding Chirocaine

Temodal receives positive recommendation for one indication from FDA advisory committee

First vaccine for Lyme disease now available from SB in the U.S.

PathoGenesis puts development of TB drug on hold

European study establishes long-term efficacy and safety of alprostadil alfadex

Medeva acquires license for scleroderma Rx from Connetics

Priority review status granted for Merck & Co.'s COX-2 inhibitor

PAF antagonist safe but not effective in the treatment of ulcerative colitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...